Floatz logo

15 assets in Bile Duct Carcinoma

Therapeutic assets addressing Bile Duct Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Bile Duct Carcinoma
National Cancer Institute (NCI)P1CC (43)
Elimusertib
Bile Duct Carcinoma
National Cancer Institute (NCI)P1CC (43)
Ropidoxuridine
Bile Duct Carcinoma
National Cancer Institute (NCI)P1CC (41)
177lu-dota-sna040
Bile Duct Carcinoma
SmartNuclide BiopharmaEarly P1C (39)
[18f]f-resca-g5
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[18f]f-resca-rb14
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[18F]F-RESCA-RND20
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[18F]F-RESCA-T4
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[18f]f-resca-wwh347
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-DOTA-H2D3
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-g5
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-rnd20
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-t4
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Bile Duct Carcinoma
RenJi HospitalN/AD (30)
Tripegfilgrastim
Bile Duct Carcinoma
National Cancer Center, KoreaP2NR ()